TP53 and renal carcinoma: According to the literature, TG2 can promote aggregation and depletion of p53 through autophagy in renal carcinoma cells, while suppression of endogenous TG2 in neuroblastoma cells leads to a significant increase in the activity of p53, including its phosphorylated forms.